IQVIA Holdings | IQV - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Accenture 13.39 1.89 2026-03
Agilent 20.53 4.51 2026-03
Bruker 36.79 44.56 2026-03
Cardinal Health 30.4 5.87 2026-03
Celltrion 58.97 8.86 2026-03
Charles River Laboratories 29.26 14.31 2026-03
Cigna 10.56 0.76 2025-12
Cognizant Technology Solutions 11.35 4.14 2026-03
Cspc Pharmaceutical 24.4 1.13 2025-12
CVS Health 9.65 4.74 2026-03
Danaher 29.29 10.39 2026-03
Dentsply International 20.31 9.68 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 59.75 6.76 2026-03
Elevance Health 17.11 4.71 2026-06
Humana 11.07 14.98 2026-03
IBM 24.1 5.96 2026-03
Illumina 32.45 2.07 2026-03
Infosys 24.15 2.67 2025-12
Kangmei Pharma 1.11K 2.04K 2026-03
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Laboratory Of America 25.51 4.65 2026-03
Malin Corporation 11.81 0.72 2023-06
McKesson 23.85 0.07 2025-12
Mettler Toledo International 27.34 5.07 2026-03
Organigram Holdings 12.01 222.99 2026-03
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 19.13 1.72 2026-03
Publicis 11.94 0.89 2026-06
Qiagen NV 20.54 0.1 2025-12
Quest Diagnostics 22.4 2.63 2026-03
Revvity 30.79 19.08 2026-03
Sartorius 43.44 84.64 2026-03
Sino Biopharmaceutical 17.03 0.89 2025-06
Thermo Fisher Scientific 27.71 3.29 2026-03
Tilray 11.56 80.19 2025-09
UnitedHealth 20.96 5.68 2026-06
Veeva Systems 26.77 9.47 2026-03
Veradigm 11.15 4.63 2022-09
Waters 29.75 5.54 2026-03
Zealand Pharma A/S 5.13 0.16 2025-12
Zz Pientze Pharmaceu 47.68 1.35 2026-03